Bisphenol A Linked to Chemotherapy Resistance
CINCINNATIExposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists.
The research study, led by UCs Nira Ben-Jonathan, PhD, says that BPAa man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cansactually induces a group of proteins that protect cancer cells from the toxic effects of chemotherapy.
The findings are reported in the journal Environmental Health Perspectives and appear online Oct. 8, 2008, ahead of print.
Resistance to chemotherapy is a major problem for cancer patients, especially those with advanced or metastatic disease, says Ben-Jonathan, a professor of cancer and cell biology at UC who has studied BPA for more than 10 years. Finding out what contributes to that resistance can give us an idea of what to target in order to make chemotherapy as effective as possible.
Researchers have suspected that BPA could play a role in cancer because of the chemicals structural similarities to a cancer-promoting compound called diethylstilbestrol (DES). But Ben-Jonathans team found that BPA isnt exactly mimicking the action of DES.
BPA does not increase cancer cell proliferation like DES does, she says. Its actually acting by protecting existing cancer cells from dying in response to anti-cancer drugs, making chemotherapy significantly less effective.
Ben-Jonathans team studied human breast cancer cells, subjecting them to low levels of BPA consistent with levels found in the blood of human adults. The team found that BPA is acting in cancer cells similar to the way estrogen doesby inducing proteins that protect the cells from chemotherapy agents.
Estrogens protein-inducing action has been previously linked to chemotherapy resistance, but researchers have been unable to explain why such resistance still occurs in certain patients with less estrogen. Ben-Jonathan says her teams research has important implications for this subgroup of patients.
Patients with less circulating estrogenpost-menopausal women, for examplecan also suffer from chemotherapy resistance, she says. Linking BPA to this problem gives us one more avenue to explore in terms of preventing chemotherapy resistance.
These data, study authors write, provide considerable support to the accumulating evidence that BPA is hazardous to human health.
Coauthors include Elizabeth LaPensee, Sejal Fox and Traci Tuttle.
The study was funded by grants from the National Institutes of Health, the Department of Defense and the Susan G. Komen Breast Cancer Foundation.
The cancer and cell biology department at UC is part of a joint cancer program involving the UC College of Medicine, Cincinnati Childrens Hospital Medical Center and University Hospital. The collaborative initiative brings together interdisciplinary research teams of caring scientists and health professionals to research and develop new cures, while providing a continuum of care for children, adults and families with cancer.
Related Stories
Can new rules in Ohio address a pharmacy staffing shortage and...
May 17, 2024
The University of Cincinnati's Michael Hegener joined WVXU's Cincinnati Edition to discuss recent rules released by the Ohio Board of Pharmacy designed to address pharmacy staffing.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
UC study: Severe ischemic strokes rare in total patient...
May 15, 2024
The University of Cincinnati’s Yasmin Aziz will present research at the European Stroke Organisation Conference that found severe ischemic strokes with the most severe damage are rare in the total stroke patient population.